IBA and Elekta enter an MOU
FTSE 250, industry-leading device & formulation business for inhaled airways disease
Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.
Consilium Healthcare - RT @ibaworldwide: IBA and Elekta enter an MOU regarding a comprehensive partnership. Read the full press release on https://t.co/v9iXwPk3fz